India shows U.S. path to patent standards, By Swaminathan S. Anklesaria Aiyar MAY 6, 2013

New Drug Approvals

Swaminathan S. Anklesaria Aiyar

Swaminathan S. Anklesaria Aiyar is a research fellow at the Center for Global Liberty and Prosperity at the Cato Institute. He was India correspondent for The Economist for two decades and served as the editor of India’s two largest financial daily papers. He is the author of “Escape From The Benevolent Zookeepers: The Best Of Swaminomics.”
read all at

View original post


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s